Human Apolipoprotein C1 VLDL Lyophilized

<strong>Human Apolipoprotein C1 VLDL Lyophilized</strong>_x000D_ <strong>Catalog number:</strong> B2016093_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 50 µg_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -70°C_x000D_ <strong>Keywords:</strong> Human Apolipoprotein C1 VLDL Purified Lyophilized_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Kovrov O, Landfors F, Saar-Kovrov V, Näslund U, Olivecrona G. Lipoprotein size is a main determinant for the rate of hydrolysis by exogenous LPL in human plasma J Lipid Res. 2022 Jan;63(1):100144._x000D_ 2: Berbée JF, van der Hoogt CC, Sundararaman D, Havekes LM, Rensen PC. Severe hypertriglyceridemia in human APOC1 transgenic mice is caused by apoC-I-induced inhibition of LPL J Lipid Res. 2005 Feb;46(2):297-306._x000D_ 3: Yui Y, Aoyama T, Morishita H, Takahashi M, Takatsu Y, Kawai C. Serum prostacyclin stabilizing factor is identical to apolipoprotein A-I (Apo A-I). A novel function of Apo A-I J Clin Invest. 1988 Sep;82(3):803-7._x000D_ 4: Conde-Knape K, Bensadoun A, Sobel JH, Cohn JS, Shachter NS. Overexpression of apoC-I in apoE-null mice: severe hypertriglyceridemia due to inhibition of hepatic lipase J Lipid Res. 2002 Dec;43(12):2136-45._x000D_ 5: Harding DR, Hancock WS, Sparrow JT. Synthesis of peptide labelled with p-iodophenylalanine which corresponds to the first amphipathic region of apolipoprotein C-I Int J Pept Protein Res. 1985 Aug;26(2):208-13._x000D_ 6: Fang D, Gong R, O K. [Isolation of isoforms of apolipoprotein CIII from human serum by chromatofocusing] Hua Xi Yi Ke Da Xue Xue Bao. 1999 Mar;30(1):111-3._x000D_ 7: Weisweiler P, Friedl C, Schwandt P. Isolation and quantification of apolipoproteins C-I, C-II, and C-III0-2 in very-low-density lipoproteins by "high-performance" anion-exchange chromatography Clin Chem. 1986 Jun;32(6):992-4._x000D_ 8: Hancock WS, Harding DR, Barling PM, Sparrow JT. Selective labelling of apolipoproteins A-I and C-I at methionine residues by (3H) methyl exchange Int J Pept Protein Res. 1985 Jul;26(1):105-8._x000D_ 9: Fuior EV, Gafencu AV. Apolipoprotein C1: Its Pleiotropic Effects in Lipid Metabolism and Beyond Int J Mol Sci. 2019 Nov 26;20(23):5939._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/36471375">10: Rouland A, Masson D, Lagrost L, Vergès B, Gautier T, Bouillet B. Role of apolipoprotein C1 in lipoprotein metabolism, atherosclerosis and diabetes: a systematic review Cardiovasc Diabetol. 2022 Dec 5;21(1):272. </a>_x000D_ _x000D_ <strong>Products Related to Human Apolipoprotein C1 VLDL Lyophilized can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>